...
首页> 外文期刊>Clinical and Experimental Otorhinolaryngology >Evaluation of Prognostic Factors for the Parotid Cancer Treated With Surgery and Postoperative Radiotherapy
【24h】

Evaluation of Prognostic Factors for the Parotid Cancer Treated With Surgery and Postoperative Radiotherapy

机译:用手术和术后放疗治疗腮腺癌预后因素的评价

获取原文

摘要

Objectives. To investigate the prognostic factors and treatment outcomes of primary parotid carcinoma treated with surgery and postoperative radiotherapy (PORT).Methods. We reviewed retrospectively 57 patients with primary parotid carcinoma who were treated with surgery and PORT between 2005 and 2014. Superficial parotidectomy was performed in 19 patients, total parotidectomy in 10 patients, and total parotidectomy with lymph node dissection in 28 patients PORT on the tumor bed was performed in 41 patients, while PORT on tumor bed and ipsilateral cervical lymph nodes was performed in 16 patients.Results. With a median follow-up of 66 months, the 5-year overall survival, disease-free survival, locoregional control, and distant control rates were 77.0%, 60.2%, 77.6%, and 72.8%, respectively. The 5-year overall survival by stage was 100%, 100%, 80.0%, and 46.4% in stage I, II, III, and IV, respectively. Recurrences at primary lesions were found in seven patients, while at cervical nodes in six patients. Distant recurrences were developed in 12 patients. No patient with the low and intermediate histologic grade developed distant failure. As prognostic factors, the histologic grade for overall survival (P=0.005), pathological T-stage (P=0.009) and differentiation grade (P=0.009) for disease-free survival, pathological T-stage for locoregional control (P=0.007), and lympho-vascular invasion (P=0.023) for distant recurrence were significant on multivariate analysis.Conclusion. This study revealed that differentiation grade, histologic grade, pathological T-stage, and lympho-vascular invasion were significant independent prognostic factors on clinical outcomes.
机译:目标。探讨用手术和术后放疗治疗原发性腮腺癌的预后因素和治疗结果(端口)。方法.Methods。我们回顾了57名患有手术和港口的患者2005年至2014年港口的患者。浅表腮腺切除术在19名患者中进行,10名患者的总腮腺切肌细胞,28例患者淋巴结解剖的总腮腺切向术术患者肿瘤床在41名患者中进行,而16名患者进行肿瘤床和同侧宫颈淋巴结的港口。结果。随着66个月的中位随访,5年整体存活,无病生存,招待控制和远处控制率分别为77.0%,60.2%,77.6%和72.8%。阶段的5年整体生存率分别为100%,100%,80.0%和46.4%,分别为阶段,II,III和IV。在六名患者中发现了初级病变的复发,而六名患者的宫颈节点。在12名患者中开发了遥远的复发。没有患有低和中间组织学等学的患者发育远处失败。作为预后因素,整体存活的组织学等分(P = 0.005),病理T-阶段(P = 0.009)和分化级(P = 0.009),用于疾病存活,病理T-阶段用于型局部控制(P = 0.007 )和淋巴血管侵袭(p = 0.023)对于多变量分析对远处复发性显着。结论。结论。该研究表明,分化级,组织学等分,病理T-阶段和淋巴血管侵袭是对临床结果的显着独立的预后因素。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号